|
|
Дата |
|---|
| 18.11.2026 |
| 17.11.2026 |
| 16.11.2026 |
| 13.11.2026 |
| 12.11.2026 |
| 11.11.2026 |
| 10.11.2026 |
| 09.11.2026 |
| 06.11.2026 |
| 05.11.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
24.93
|
33.99
|
31.51
|
30.75
|
32.27
|
31.495
|
|
|
954 616.87
|
421.00
|
|
27.00
|
34.00
|
29.29
|
29.29
|
31.78
|
30.78
|
|
|
2 662 334.04
|
630.00
|
|
11.44
|
33.84
|
31.79
|
28.47
|
31.79
|
28.48
|
|
|
646 577.78
|
209.00
|
|
12.60
|
33.96
|
32.70
|
31.21
|
32.70
|
31.21
|
|
|
289 044.43
|
216.00
|
|
13.02
|
33.96
|
30.91
|
30.91
|
33.33
|
32.92
|
|
|
2 838 518.20
|
537.00
|
|
12.78
|
33.84
|
31.50
|
31.22
|
33.485
|
32.04
|
|
|
1 629 439.07
|
377.00
|
|
12.36
|
50.20
|
30.53
|
29.84
|
31.50
|
31.47
|
|
|
1 225 310.14
|
358.00
|
|
11.96
|
48.62
|
29.79
|
29.79
|
30.68
|
30.47
|
|
|
310 209.28
|
164.00
|
|
18.08
|
48.13
|
29.66
|
29.66
|
30.805
|
30.43
|
|
|
1 823 242.29
|
357.00
|
|
28.47
|
46.31
|
28.80
|
28.35
|
29.04
|
28.80
|
|
|
254 325.25
|
206.00
|
Lycia Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases. Its immunoglobulin E (IgE) portfolio consists of LCA-0061 and LCA-0062. The LCA-0061 is an antibody-small molecule conjugate cataLYTAC degrader designed to target and degrade IgE, a known driver of multiple allergic diseases, including food allergy, allergic asthma, allergic rhinitis, chronic spontaneous urticaria and chronic rhinosinusitis with nasal polyps.
The LCA-0062 bispecific antibody cataLYTAC degrader is designed to target and degrade IgE, it is designed to degrade multiple copies of IgE per LYTAC degrader. LCA-0321 is a protein-small molecule conjugate classic LYTAC degrader which is designed to selectively degrade TRAbs, the pathogenic drivers of Graves' disease.
Показать все Скрыть